Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture.

Area of Science:

• Developmental Biology
• Hematopoiesis
• Stem Cell Biology

Background:

• Embryonic stem cells (ESCs) can differentiate into various cell types in vitro.
• Embryoid bodies (EBs) are three-dimensional aggregates formed by ESCs, mimicking early embryonic development.
• Hematopoietic differentiation, including erythropoiesis, is a key developmental process studied in EBs.

Purpose of the Study:

• To investigate the hematopoietic differentiation potential of ESCs cultured in semisolid media.
• To analyze the role of specific growth factors, erythropoietin (Epo) and interleukin-3 (IL-3), in modulating hematopoietic differentiation within EBs.

Main Methods:

• Culture of ESCs in methyl cellulose to form EBs.
• Analysis of erythropoietic cell presence and globin mRNA expression within EBs.
• Treatment of EBs with Epo and IL-3 to assess their effects on differentiation.
• Assessment of macrophage, mast cell, and neutrophil development in response to IL-3.

Main Results:

• EBs spontaneously generated erythropoietic cells, with beta H1 globin mRNA appearing by day 5 and beta(maj)-globin RNA by day 6.
• Epo increased the frequency and duration of erythropoiesis in EBs.
• IL-3 did not significantly increase erythroid cell frequency but promoted the development of macrophages, mast cells, and neutrophils.
• IL-3, alone or with other cytokines, enhanced macrophage development, and long-term mast cell output was observed upon EB attachment.

Conclusions:

• ESCs in EBs provide a model for studying hematopoietic differentiation, particularly erythropoiesis.
• Epo and IL-3 are key regulators of hematopoietic lineage commitment and maturation within EBs.
• This system allows for the investigation of cytokine-driven hematopoiesis and the generation of specific hematopoietic cell types.